Financials of Natco Pharma Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Natco Pharma Ltd

Quarterly Results

Quarter-by-quarter operating performance

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales +4928981,1401,0317591,0681,3631,3714751,2211,3291,363647
Expenses +387559612573490571558567436673758784489
Operating Profit10633952845826849780580439548571579159
OPM %22%38%46%44%35%47%59%59%8%45%43%42%25%
Other Income +2129202937424864176666210058
Interest4344565441031310
Depreciation42414444445644464798585246
Profit before tax81324500440256478804818164506572614161
Tax %23%15%16%16%17%19%17%17%19%20%16%16%13%
Net Profit +62276420369213386668676132406480518151
EPS in Rs3.4115.1123.4720.6011.8821.5737.3237.817.4322.7026.8428.948.46

Financials of Natco Pharma Ltd

Profit & Loss

Annual income statement trend

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales +7398251,0422,0202,1852,0941,9152,0521,9452,7073,9994,4304,560
Expenses +5606157771,3371,2561,3001,3321,4461,6811,7722,2452,2342,703
Operating Profit1792102666839287955836062649361,7542,1961,857
OPM %24%25%25%34%42%38%30%30%14%35%44%50%41%
Other Income +17012144013010710499105126354286
Interest37322318151922131814192436
Depreciation304751546681100117143164187235254
Profit before tax1291322046248878255695802028621,6742,2911,853
Tax %24%1%24%22%22%22%19%24%16%17%17%18%
Net Profit +981301564856956424584421707151,3881,8831,556
EPS in Rs6.218.109.0227.8837.7435.2425.3124.189.3139.1877.51105.2686.94
Dividend Payout %16%12%14%24%22%18%27%22%48%14%12%6%

Financials of Natco Pharma Ltd

Balance Sheet

Capital structure and asset base

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital33333535373636363636363636
Reserves6938131,2611,6143,0353,4523,7374,0854,2274,8375,8177,5718,614
Borrowings +240312113222173386316268416167371279261
Other Liabilities +2292264134464704284984034306176827441,520
Total Liabilities1,1961,3841,8222,3183,7154,3034,5884,7925,1095,6576,9068,63110,430
Fixed Assets +6457107108331,0191,2271,5842,0232,3122,4272,4912,6982,697
CWIP12412921233648063851822313064137225255
Investments22223276169112304308392539474774
Other Assets +4255438781,1162,1402,2702,3732,2422,3602,7743,7395,2346,704
Total Assets1,1961,3841,8222,3183,7154,3034,5884,7925,1095,6576,9068,63110,430

Financials of Natco Pharma Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +14493112346464669417299468491,2121,697
Cash from Investing Activity +-108-120-176-299-1,116-611-175-1074-465-1,026-1,436
Cash from Financing Activity +-3529154-48651-51-251-18635-363-247-211
Net Cash Flow0290-1-27-868521-6250
Free Cash Flow34-25-4466572258192-1426748551,300
CFO/OP100%55%60%69%72%107%90%71%36%110%85%94%

Financials of Natco Pharma Ltd

Ratios

Working capital efficiency and return ratios

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days598592861068810573116115109103
Inventory Days283331482213389545534570496432357405
Days Payable172189372160239224244104105153120145
Cash Conversion Cycle170228202138257410395539507394345362
Working Capital Days22259771215207295246258198151151
ROCE %18%17%18%39%35%23%14%13%4%18%30%33%